Greater disease severity in adults with paediatric-onset versus adult-onset bronchiectasis: a multicentre EMBARC registry study
European Respiratory Journal · 2026
DOI: 10.1183/13993003.00665-2025 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Luai Khalaili und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Institute, Carmel Medical Center, Haifa, Israel. Hauptthemen laut MEDLINE: Bronchiectasis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Young adults with paediatric-onset bronchiectasis (POBE) represent a minority of bronchiectasis patients and are poorly characterised. We aimed to compare the characteristics and severity of adults with POBE to adult-onset bronchiectasis (AOBE).
Methods
Data from four EMBARC (European Multicentre Bronchiectasis Audit and Research Collaboration) centres were analysed. POBE was defined as patient-reported symptom onset before the age of 18 years, while AOBE was defined as symptom onset at or after the age of 18 years. We compared POBE to AOBE and used multivariable models to identify factors associated with disease severity, including lung function, Pseudomonas aeruginosa infection, exacerbations and hospitalisations.
Results
Among 1422 patients, 249 (17.5%) had POBE (mean onset age: 6.5 years) and 1173 had AOBE (mean onset age: 55.4 years). POBE patients were younger at enrolment (50.3 versus 66 years), had longer disease duration (43.3 versus 10.8 years), worse lung function (forced expiratory volume in 1 s (FEV 1 ): 70.8% versus 84.2% predicted), greater radiological extent (Reiff score: 6.0 versus 4.4), higher bacterial infection rates (72.3% versus 54.6%) and more exacerbations (median: 2 versus 1 per year) compared to AOBE (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pulmonology Institute, Carmel Medical Center, Haifa, Israel.
- B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
- Respiratory Unit, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Division of Respiratory Medicine and Gastroenterology, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
- Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
ORCID-Profile: Stefano Aliberti, Francesco Blasi, Benjamin Jaaming New, James D Chalmers, Michal Shteinberg
Zitieren
APA
Khalaili, L., Aliberti, S., Viligorska, K., Blasi, F., Stein, N., Cohen, R., Zoubi, R., Adir, Y., De Angelis, A., New, B. J., Marshall, L., Chalmers, J. D., & Shteinberg, M. (2026). Greater disease severity in adults with paediatric-onset versus adult-onset bronchiectasis: a multicentre EMBARC registry study. European Respiratory Journal. https://doi.org/10.1183/13993003.00665-2025
Vancouver
Khalaili L, Aliberti S, Viligorska K, Blasi F, Stein N, Cohen R, et al. Greater disease severity in adults with paediatric-onset versus adult-onset bronchiectasis: a multicentre EMBARC registry study. European Respiratory Journal. 2026. doi:10.1183/13993003.00665-2025
BibTeX
@article{Khalaili2026,
author = {Khalaili, Luai and Aliberti, Stefano and Viligorska, Kateryna and Blasi, Francesco and Stein, Nili and Cohen, Raya and Zoubi, Rafea and Adir, Yochai and De Angelis, Alessandro and New, Benjamin Jaaming and Marshall, Lewis and Chalmers, James D and Shteinberg, Michal},
title = {Greater disease severity in adults with paediatric-onset versus adult-onset bronchiectasis: a multicentre EMBARC registry study},
journal = {European Respiratory Journal},
year = {2026},
doi = {10.1183/13993003.00665-2025}
}
EUVIMED